TRIOFAN Antitussif sirop fl 200 ml

7680539540012 CH-53954 R05DB13 03.01.2.
TRIOFAN Antitussif sirop fl 200 ml
TRIOFAN Antitussif sirop fl 200 ml
TRIOFAN Antitussif sirop fl 200 ml
1 / 3
google

Details

Product number
5395401
CPT
-
Packaging group
200
Unit
ml
Composition
butamirati dihydrogenocitras 15 mg corresp. butamiratum 9.3 mg, aromatica, color.: E 150a, conserv.: E 210, excipiens ad solutionem pro 10 ml.

Articles (1)

Triofan Antitussif, sirop
Sirup
200
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
17/06/2025
Patient information leaflet
Français
17/06/2025
Patient information leaflet
Italien
17/06/2025
Professional SmPC
Allemand
05/10/2023
Professional SmPC
Français
05/10/2023

Detailed composition

Substance Quantity Type Category
(N/A)
15.0 MG Substance WIZUS
(N/A)
9.3 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance AROMA
(N/A)
- Substance FIMDK
(N/A)
- Substance Konservierungsstoff (Conservateur)

Authorization holder

Verfora SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
53954
Drug name
Triofan Antitussif, sirop
Galenic form
SIRU
ATC Code
R05DB13
Authorization status
Z
Dispensation category
D
First authorization
07/05/1997
Authorization expiration date
31/12/9999
IT number
03.01.2.
Domain
Human medicine
Field of application
Husten

Packaging details

Description (FR)
TRIOFAN Antitussif sirop fl 200 ml
Description (DE)
TRIOFAN Hustenstiller Sirup Fl 200 ml
Market launch
07/05/1997
Narcotic (BTM)
No

Other packaging sizes